News
MedPage Today on MSN1d
Kidney Transplantation Without Lifelong Immunosuppression Edges Toward RealityThe primary endpoint was functional immune tolerance, defined as off all immunosuppressive drugs 24 months after ...
Advances in blood stem cell transplants now make it possible for people with blood cancers to get safe and effective "mismatched" transplants that ...
HealthDay on MSN4h
Cell Therapy MDR-101 Produces Functional Immune Tolerance in Kidney Transplant RecipientsKidney transplant recipients receiving the investigational cellular product MDR-101 achieved functional immune tolerance for ...
Kidney transplant recipients who receive donor-derived hematopoietic stem cells may be able to discontinue immunosuppressive ...
MiNK Therapeutics surged on tumor remission data for agenT-797, but financial risks and limited clinical proof remain. Learn ...
MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg® in acute Graft-versus Host Disease ...
Stocktwits on MSN4d
MiNK Therapeutics Stock Soars On Patient Receiving Full Remission In Testicular Cancer With Investigational Cell TherapyShares of MiNK Therapeutics, Inc. (INKT) skyrocketed on Friday following the publication of a case from its clinical trial ...
Dr. Simrit Parmar, a Northwestern University-trained oncologist and research scientist, launched Cellenkos Inc., in 2016 to ...
Achieving donor chimerism or GVHD after infusion boosted survival only in relapse cases without prior GVHD, revealing a key ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback